Amelioration of Murine Diabetic Nephropathy with a SGLT2 Inhibitor Is Associated with Suppressing Abnormal Expression of Hypoxia-Inducible Factors

Akari Inada(Life Science Institute), Atsushi Fukatsu(Komatsu (Japan))
American Journal Of Pathology
April 20, 2022
Cited by 17


Related Papers